The dualistic nature of PFAS-induced epigenetic modifications, encompassing both hypo- and hypermethylation events that can activate oncogenic pathways or suppress tumor suppressor genes [218], is further underscored by parallels drawn with mechanisms implicated in cancer immunotherapy resistance [219]. The gene discussed is PFAS; the disease is neoplasm.